FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 30.43

Change

-0.28 (-0.91)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-0.69 (-0.51%)

USD 18.06B
VOT Vanguard Mid-Cap Growth Index ..

-0.05 (-0.02%)

USD 15.90B
IJK iShares S&P Mid-Cap 400 Growth..

-0.05 (-0.06%)

USD 8.83B
XMMO Invesco S&P MidCap Momentum ET..

+0.21 (+0.17%)

USD 3.81B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-0.26 (-0.23%)

USD 1.08B
CWS AdvisorShares Focused Equity E..

+0.02 (+0.02%)

USD 0.18B
ETHO Amplify ETF Trust

-0.07 (-0.12%)

USD 0.18B
BFOR Barron's 400 ETF

-0.10 (-0.14%)

USD 0.15B
IPO Renaissance IPO ETF

-0.48 (-1.10%)

USD 0.14B
PEXL Pacer US Export Leaders ETF

-0.21 (-0.43%)

USD 0.04B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.44% 94% A 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.44% 94% A 76% C+
Trailing 12 Months  
Capital Gain 9.26% 63% D 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.26% 63% D 65% D
Trailing 5 Years  
Capital Gain -6.31% 11% F 34% F
Dividend Return 2.64% 17% F 6% D-
Total Return -3.68% 6% D- 19% F
Average Annual (5 Year Horizon)  
Capital Gain -4.74% 17% F 16% F
Dividend Return -4.05% 17% F 11% F
Total Return 0.69% 61% D- 16% F
Risk Return Profile  
Volatility (Standard Deviation) 26.13% 17% F 35% F
Risk Adjusted Return -15.50% 17% F 16% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.